Date Title Description PDF
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
29 Dec 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 22 December and 28 December 2023 Download
22 Dec 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 15 December and 21 December 2023 Download
15 Dec 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 11 December and 14 December 2023 Download
11 Dec 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 1 December and 8 December 2023 Download
01 Dec 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 24 November and 30 November 2023 Download

Pages

Date Title Description PDF
31 Jan 2020 R&D: new licenses, patents and registered trademarks The Company informs about the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union Download
08 Jan 2020 Liquidity contracts and specialists Liquidity contract: transactions conducted in the fourth quarter of 2019 Download
20 Dec 2019 Composition of the board of directors The Company informs about the composition of its Board of Directors and its Audit and Appointments and Remuneration Committees. Download
24 Nov 2019 Strategic plans, profit forecasts and presentations The Company releases the presentation related to its strategy update because of the 2019 Investor Day. Download
07 Nov 2019 Information on P&L ROVI releases the press release related to the first nine months 2019 financial results Download

Pages